News
Merck KGaA to Acquire Bio-Techne (TECH) for $11.3B at 36% Premium; Shares Surge 19%
Merck KGaA announced a $11.3 billion all-cash bid for Bio-Techne (TECH) at $73 per share — a 36% premium to the one-month VWAP and the German group's biggest deal since Sigma-Aldrich. TECH shares surged 19% intraday.